Registration now open! Following on from the positive feedback that we received from participants who attended our inaugural webinar last year, the National Centre for Pharmacoeconomics (NCPE) is once again hosting a webinar for Patient Organisations. The title is: Patient Organisation Involvement in National and European Health Technology Assessment We […]
The European Commission has launched the first call for medicinal products for Joint Scientific Consultations (JSC) on behalf of the HTACG. JSCs offer HTDs the opportunity to seek advice on the technology from HTA bodies. The HTACG will conduct up to 10 JSCs in 2025 and look to increase capacity […]
The NCPE has welcomed the introduction of new European legislation for Health Technology Assessment. The EU Health Technology Assessment Regulation (HTAR) comes into effect on January 12, 2025 enabling joint assessments of health technologies (medicinal products and medical devices) across EU Member States. The full statement from the NCPE regarding […]
Version 2.1 of the Budget Impact Model was published on 8th of January 2025 and replaces version 2.0. The new version is available here. The NCPE have published the NCPE Budget Impact Guideline. The aim of this guideline is to provide guidance on the conduct of a drug budget impact […]
Version 3.0 of the Full HTA Submission Template is available here. This template, to be completed by Applicants, outlines the content and format of the written submission to the NCPE as part of a full HTA. For those companies who have already started to prepare a full HTA submission, the […]
Dr. Roisin Adams, NCPE elected as Chair of the Health Technology Assessment Coordination Group. On 28 November 2022, the HTA Coordination Group (HTACG) elected its Chair, Dr. Roisin Adams, National Centre for Pharmacoeconomics, Ireland and co-chairs, Niklas Hedberg Dental and Pharmaceuticals Benefits Agency, Sweden and Marco Marchetti, National Agency for […]
Notice to Applicants: Please refer to updated versions of the RR Submission Template v2.2, Applicant Template v2.1, and the Submission Checklist v1.4 when making submissions. These are available from the Submission Templates section of the website.
Version 2.1 of the Rapid Review Submission templates includes a requirement to submit the NCPE Budget Impact Model Template for all Rapid Review submissions. Version 2.1 of this template was published on 07 April 2022 and replaces version 2.0. Submissions using the old template (version 2.0) will be accepted until 12 May 2022.
Latest Updates…
Press Release HAG EUNETHTA21 – Professor Michael Barry, Director of the National Centre for Pharmacoeconomics joins the inaugural Heads of Agency Group.